Bradley J. Bolzon Phd.

Director, Flexion Therapeutics.

Companies

CRISPR TherapeuticsBoard member Oct 18, 2016 to Jun 10, 2022¹
Monte Rosa TherapeuticsBoard member Jun 23, 2021 to Jun 30, 2021²
Black Diamond Therapeutics, Inc.Board member Jan 29, 2020 to Jun 22, 2021³
Flexion TherapeuticsBoard member Feb 11, 2014 to Sep 12, 2014⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCRISPR Therapeutics, Board member
2
SEC EDGARMonte Rosa Therapeutics, Board member
3
SEC EDGARBlack Diamond Therapeutics, Inc., Board member
4
SEC EDGARFlexion Therapeutics, Board member